MA MEng Manufacturing Engineering and Management, University of Cambridge
“It’s my mission to help bring innovative treatments to market for the benefit of patients and their families: I was a young caregiver myself. I’m passionate about helping pharma/biotech companies develop solutions that are problem-focussed, customer-oriented, and pragmatic to deploy. This is an ever-changing challenge as new consumer, regulatory, scientific, and technology trends are shifting the market and competitive environment. Novasecta understands this context and tailors each engagement to fit its client’s situation”
Emma Dabbs is a Manager and leads projects across all three practices: corporate, R&D, and commercial strategy. Emma has 8 years of life sciences strategy experience and has worked with clients throughout the industry, including: big pharma to emerging biotechs; public healthcare providers, commissioners, and regulators; and digital/medtech businesses.
Prior to Novasecta, Emma was a Manager in Monitor Deloitte’s Life Science and Healthcare practices, supporting NHS and Pharma clients to transform their businesses and develop approaches to address market and regulatory trends e.g. early access schemes, biosimilar entrants, orphan diseases, cross-functional launch planning, and strategic collaborations.
In 2015, Emma joined the NHS for 18 months as Patient Safety Lead for Imperial College Health Partners to catalyse innovation and collaboration across NHS organisations, academia, and industry.
Emma started her career with boutique strategy consulting firm Kaiser Associates. In this role she led engagements to drive commercial excellence and develop innovative digital solutions. Lastly, Emma leverages her engineering background to apply holistic systems-thinking, user-centred design, and lean six sigma concepts to challenges.